Phosphates du Protérozoïque supérieur dans la chaîne des Dahomeyides (circa 600 Ma) de la région de Bassar (Nord-Togo, Afrique de l'Ouest)

Les phosphates de Bassar (nord du Togo) sont situés dans la partie tectonisée de la couverture du craton ouest-africain, et plus précisément dans les schistes de l'unité structurale de l'Atacora de la chaîne des Dahomeyides. Les roches phosphatées se présentent comme des intercalations d'épaisseur variables (< 30 m). Elles sont généralement constituées de pellets d'apatite plus ou moins pure et recristallisée enrobés dans une matrice essentiellement phosphatée. Ce gisement s'ajoute notamment aux indices d'Aloub Djouana et de Pagala et démontre ainsi une extension fort intéressante des phosphates précambriens dans les unités tectonisées au front des Dahomeyide

Formation of the Xigaze Metamorphic Sole under Tibetan continental lithosphere reveals generic characteristics of subduction initiation

Metamorphic soles found under allochthonous oceanic lithosphere, or ophiolites, are interpreted as derived from lower plate oceanic crust material accreted to upper plate mantle during intraoceanic subduction initiation. Their metamorphic evolution is inferred to reflect the thermal structure at the site of subduction nucleation, with granulite-bearing soles linked to initiation at hot spreading centers. Here we present garnet Lu-Hf geochronology for the granulite-bearing sole of the Xigaze ophiolite in South Tibet, whose oceanic crust formed ∼130 Ma through continental forearc extension. Our study shows that sole metamorphism was ongoing by 144 Ma, implying that north-directed subduction began at least 14 million years before oceanic forearc spreading. The upper plate at the time of subduction initiation was thus continental, not oceanic. Our results demonstrate that metamorphic characteristics of soles are independent of the specific tectonic setting at the subduction nucleation site and rather provide generic constraints on the subduction initiation process

Producers of Engineered Nanomaterials-What Motivates Company and Worker Participation in Biomonitoring Programs?

Production and handling of engineered nanomaterials (ENMs) can yield worker exposure to these materials with the potential for unforeseen negative health effects. Biomonitoring enables regular exposure and health assessment and an effective risk management. We aimed to identify factors influencing biomonitoring acceptance according to hierarchical positions of ENM producers. Managers and workers were invited to complete an online questionnaire. Forty-three companies producing or handling ENMs such as titanium dioxide (61%) and multi-walled carbon nanotubes (44%) participated. The majority of managers (72%) and all workers responded positively to participating in biomonitoring studies. The main reasons for refusing participation included concerns about data confidentiality and sufficient knowledge about ENM health and safety. Acquisitions of individual study results, improvement of workers' safety, and help to the development of ENM-specific health and safety practice were among the most valuable reasons for positively considering participation. All workers indicated feeling comfortable with biomonitoring procedures of exhaled air sampling-about half were similarly comfortable with exhaled breath condensate, urine, and buccal cell sampling. The majority of both workers and managers stated that participation in a biomonitoring program should take place during working hours. Although our survey only had limited participation, our results are useful in designing appropriate biomonitoring programs for workers exposed to ENMs

The Tate conjecture for K3 surfaces over finite fields

Artin's conjecture states that supersingular K3 surfaces over finite fields have Picard number 22. In this paper, we prove Artin's conjecture over fields of characteristic p>3. This implies Tate's conjecture for K3 surfaces over finite fields of characteristic p>3. Our results also yield the Tate conjecture for divisors on certain holomorphic symplectic varieties over finite fields, with some restrictions on the characteristic. As a consequence, we prove the Tate conjecture for cycles of codimension 2 on cubic fourfolds over finite fields of characteristic p>3.Comment: 20 pages, minor changes. Theorem 4 is stated in greater generality, but proofs don't change. Comments still welcom

Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.

The fully human anti-lipopolysaccharide (LPS) immunoglobulin M (IgM) monoclonal antibody panobacumab was developed as an adjunctive immunotherapy for the treatment of O11 serotype Pseudomonas aeruginosa infections. We evaluated the potential clinical efficacy of panobacumab in the treatment of nosocomial pneumonia. We performed a post-hoc analysis of a multicenter phase IIa trial (NCT00851435) designed to prospectively evaluate the safety and pharmacokinetics of panobacumab. Patients treated with panobacumab (n = 17), including 13 patients receiving the full treatment (three doses of 1.2 mg/kg), were compared to 14 patients who did not receive the antibody. Overall, the 17 patients receiving panobacumab were more ill. They were an average of 72 years old [interquartile range (IQR): 64-79] versus an average of 50 years old (IQR: 30-73) (p = 0.024) and had Acute Physiology and Chronic Health Evaluation II (APACHE II) scores of 17 (IQR: 16-22) versus 15 (IQR: 10-19) (p = 0.043). Adjunctive immunotherapy resulted in an improved clinical outcome in the group receiving the full three-course panobacumab treatment, with a resolution rate of 85 % (11/13) versus 64 % (9/14) (p = 0.048). The Kaplan-Meier survival curve showed a statistically significantly shorter time to clinical resolution in this group of patients (8.0 [IQR: 7.0-11.5] versus 18.5 [IQR: 8-30] days in those who did not receive the antibody; p = 0.004). Panobacumab adjunctive immunotherapy may improve clinical outcome in a shorter time if patients receive the full treatment (three doses). These preliminary results suggest that passive immunotherapy targeting LPS may be a complementary strategy for the treatment of nosocomial O11 P. aeruginosa pneumonia

Balloon cells promote immune system activation in focal cortical dysplasia type 2b

AIMS: Focal cortical dysplasia (FCD) type 2 is an epileptogenic malformation of the neocortex associated with somatic mutations in the mammalian target of rapamycin (mTOR) pathway. Histopathologically, FCD 2 is subdivided into FCD 2a and FCD 2b, the only discriminator being the presence of balloon cells (BCs) in FCD 2b. While pro‐epileptogenic immune system activation and inflammatory responses are commonly detected in both subtypes, it is unknown what contextual role BCs play. METHODS: The present study employed RNA sequencing of surgically resected brain tissue from FCD 2a (n = 11) and FCD 2b (n = 20) patients compared to autopsy control (n = 9) focusing on three immune system processes: adaptive immunity, innate immunity and cytokine production. This analysis was followed by immunohistochemistry on a clinically well‐characterised FCD 2 cohort. RESULTS: Differential expression analysis revealed stronger expression of components of innate immunity, adaptive immunity and cytokine production in FCD 2b than in FCD 2a, particularly complement activation and antigen presentation. Immunohistochemical analysis confirmed these findings, with strong expression of leukocyte antigen I and II in FCD 2b as compared to FCD 2a. Moreover, T‐lymphocyte tissue infiltration was elevated in FCD 2b. Expression of markers of immune system activation in FCD 2b was concentrated in subcortical white matter. Lastly, antigen presentation was strongly correlated with BC load in FCD 2b lesions. CONCLUSION: We conclude that, next to mutation‐driven mTOR activation and seizure activity, BCs are crucial drivers of inflammation in FCD 2b. Our findings indicate that therapies targeting inflammation may be beneficial in FCD 2b

Observations of Neutron-Capture Elements in the Early Galaxy

Neutron-capture elements in low metallicity Galactic halo stars vary widely both in overall contents and detailed abundance patterns. This review discusses recent observational results on the n-capture elements, discussing the implications for early Galactic nucleosynthesis of: (a) the star-to-star ``bulk'' variations in the n-capture/Fe abundance ratios; (b) the distinct signature of rapid n-capture synthesis events in many (most?) of the lowest metallicity stars; (c) the existence of metal-poor stars heavily enriched in the products of slow n-capture synthesis reactions; and (d) the now-routine detection of radioactive thorium (and even uranium in one and possibly two cases) in the spectra of metal-poor stars.Comment: 8 pages, 3 figures; To appear in the Proceedings of the 7th International Conference on Nuclei in the Cosmo